Literature DB >> 26558546

Socioeconomic marginalization and plasma HIV-1 RNA nondetectability among individuals who use illicit drugs in a Canadian setting.

Lindsey A Richardson1, Thomas H Kerr, Sabina Dobrer, Cathy M Puskas, Silvia A Guillemi, Julio S G Montaner, Evan Wood, M-J S Milloy.   

Abstract

OBJECTIVE: Given that people who use illicit drugs (PWUD) often engage in prohibited income generation to support their basic needs, we sought to examine the role of these activities in shaping antiretroviral therapy (ART) adherence and plasma HIV RNA-1 viral load suppression among HIV-infected PWUD.
DESIGN: Longitudinal analyses among HIV-positive, ART-exposed PWUD in the AIDS Care Cohort to evaluate Exposure to Survival Services prospective cohort study (2005-2013).
METHODS: Generalized linear mixed-effects and mediation analyses examined the relationship between prohibited income generation (e.g., sex work, drug dealing, theft, street-based income) and virologic suppression (plasma viral load ≤50 copies/ml plasma) adjusting for adherence and potential confounders.
RESULTS: Among 687 HIV-infected PWUD, 391 (56.9%) individuals reported prohibited income generation activity during the study period. In multivariate analyses, prohibited income generation remained independently and negatively associated with virologic suppression (adjusted odds ratio: 0.68, 95% confidence interval: 0.52-0.88) following adjustment for hypothesized confounders, including high-intensity drug use, ART adherence and homelessness. Although partially mediated by ART adherence, the relationship between prohibited income generation and virologic suppression was maintained in mediation analyses (Sobel statistic = -1.95, P = 0.05).
CONCLUSION: Involvement in prohibited income generation decreases the likelihood of virologic suppression directly and indirectly through its negative association with ART adherence. These findings suggest that linkages between socioeconomic marginalization, the criminalization of illicit drug use, and insufficient employment opportunities may produce barriers to access and retention in care. Programmatic and policy interventions that decrease socioeconomic vulnerability may therefore reduce HIV-related morbidity, mortality, and onward transmission.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26558546      PMCID: PMC4646709          DOI: 10.1097/QAD.0000000000000853

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  36 in total

1.  Interest in low-threshold employment among people who inject illicit drugs: implications for street disorder.

Authors:  Kora Debeck; Evan Wood; Jiezhi Qi; Eric Fu; Doug McArthur; Julio Montaner; Thomas Kerr
Journal:  Int J Drug Policy       Date:  2011-06-17

Review 2.  Unemployment and substance use: a review of the literature (1990-2010).

Authors:  Dieter Henkel
Journal:  Curr Drug Abuse Rev       Date:  2011-03

3.  Patterns of heroin and cocaine injection and plasma HIV-1 RNA suppression among a long-term cohort of injection drug users.

Authors:  Thomas Kerr; Brandon D L Marshall; M-J Milloy; Ruth Zhang; Silvia Guillemi; Julio S G Montaner; Evan Wood
Journal:  Drug Alcohol Depend       Date:  2012-01-14       Impact factor: 4.492

4.  Social and environmental predictors of plasma HIV RNA rebound among injection drug users treated with antiretroviral therapy.

Authors:  M-J Milloy; Thomas Kerr; Jane Buxton; Tim Rhodes; Andrea Krusi; Silvia Guillemi; Robert Hogg; Julio Montaner; Evan Wood
Journal:  J Acquir Immune Defic Syndr       Date:  2012-04-01       Impact factor: 3.731

Review 5.  The state of engagement in HIV care in the United States: from cascade to continuum to control.

Authors:  Michael J Mugavero; K Rivet Amico; Tim Horn; Melanie A Thompson
Journal:  Clin Infect Dis       Date:  2013-06-23       Impact factor: 9.079

6.  Employment predicts decreased mortality among HIV-seropositive illicit drug users in a setting of universal HIV care.

Authors:  Lindsey A Richardson; M-J S Milloy; Thomas H Kerr; Surita Parashar; Julio S G Montaner; Evan Wood
Journal:  J Epidemiol Community Health       Date:  2013-10-23       Impact factor: 3.710

Review 7.  Heterosexual HIV-1 infectiousness and antiretroviral use: systematic review of prospective studies of discordant couples.

Authors:  Rebecca F Baggaley; Richard G White; T Déirdre Hollingsworth; Marie-Claude Boily
Journal:  Epidemiology       Date:  2013-01       Impact factor: 4.822

8.  The impact of social, structural and physical environmental factors on transitions into employment among people who inject drugs.

Authors:  Lindsey Richardson; Evan Wood; Thomas Kerr
Journal:  Soc Sci Med       Date:  2012-11-02       Impact factor: 4.634

Review 9.  Translation of biomedical prevention strategies for HIV: prospects and pitfalls.

Authors:  Sten H Vermund; José A Tique; Holly M Cassell; Megan E Pask; Philip J Ciampa; Carolyn M Audet
Journal:  J Acquir Immune Defic Syndr       Date:  2013-06-01       Impact factor: 3.731

Review 10.  Housing status and the health of people living with HIV/AIDS.

Authors:  M-J Milloy; Brandon D L Marshall; Julio Montaner; Evan Wood
Journal:  Curr HIV/AIDS Rep       Date:  2012-12       Impact factor: 5.071

View more
  18 in total

1.  Employment Cessation, Long Term Labour Market Engagement and HIV Infection Risk Among People Who Inject Drugs in an Urban Canadian Setting.

Authors:  Lindsey Richardson; Mitchell Mammel; M-J Milloy; Kanna Hayashi
Journal:  AIDS Behav       Date:  2019-12

Review 2.  Substance Use and Adherence to Antiretroviral Therapy: What Is Known and What Is Unknown.

Authors:  M Eugenia Socias; M-J Milloy
Journal:  Curr Infect Dis Rep       Date:  2018-07-31       Impact factor: 3.725

3.  Social and structural factors associated with greater time with a plasma HIV-1 RNA viral load above log10(1500) copies/ml among illicit drug users.

Authors:  Mary Clare Kennedy; Thomas H Kerr; Evan Wood; Jeannie A Shoveller; Julio S G Montaner; M-J S Milloy
Journal:  AIDS       Date:  2018-05-15       Impact factor: 4.177

4.  Longitudinal Factors Associated with Used Syringe Lending Among HIV-Positive Antiretroviral Therapy-Naïve People Who Inject Drugs in a Canadian Setting.

Authors:  Ezequiel Blumenkrans; M Eugenia Socías; Lindsey Richardson; Thomas Kerr; Jean Shoveller; Julio Montaner; M-J Milloy
Journal:  AIDS Behav       Date:  2020-07

5.  Methadone maintenance therapy and viral suppression among HIV-infected opioid users: The impacts of crack and injection cocaine use.

Authors:  M Eugenia Socías; Evan Wood; Will Small; Huiru Dong; Jean Shoveller; Thomas Kerr; Julio Montaner; M-J Milloy
Journal:  Drug Alcohol Depend       Date:  2016-09-20       Impact factor: 4.492

6.  Dispensation of antiretroviral therapy and methadone maintenance therapy at the same facility in a low-barrier setting linked to optimal adherence to HIV treatment.

Authors:  N A Mohd Salleh; N Fairbairn; S Nolan; R Barrios; J Shoveller; L Richardson; M-J Milloy
Journal:  HIV Med       Date:  2019-07-29       Impact factor: 3.180

7.  High-intensity cannabis use and HIV clinical outcomes among HIV-positive people who use illicit drugs in Vancouver, Canada.

Authors:  Stephanie Lake; Thomas Kerr; Rielle Capler; Jeannie Shoveller; Julio Montaner; M-J Milloy
Journal:  Int J Drug Policy       Date:  2017-03-21

8.  Elevated prevalence of self-reported unintentional exposure to fentanyl among women who use drugs in a Canadian setting: A cross-sectional analysis.

Authors:  Sanjana Mitra; Jade Boyd; Evan Wood; Cameron Grant; M-J Milloy; Kora DeBeck; Thomas Kerr; Kanna Hayashi
Journal:  Int J Drug Policy       Date:  2020-07-20

9.  Transitions in income generation among marginalized people who use drugs: A qualitative study on recycling and vulnerability to violence.

Authors:  Jade Boyd; Lindsey Richardson; Solanna Anderson; Thomas Kerr; Will Small; Ryan McNeil
Journal:  Int J Drug Policy       Date:  2018-07-04

10.  Prevalence and Correlates of Reporting Difficulty Taking Antiretroviral Treatment Among HIV-Positive Illicit Drug Users in Vancouver, Canada: A Longitudinal Analysis.

Authors:  Bianca Yeung; N A Mohd Salleh; Eugenia Socías; Huiru Dong; J Shoveller; J S G Montaner; M-J S Milloy
Journal:  AIDS Behav       Date:  2019-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.